Brief: India's Jagson Pal Pharma Posts Sept-Qtr Loss
12/12/2017 09:08
Dec 12 (Reuters) - Jagson Pal Pharmaceuticals Ltd JGSN.NS :
* SEPT QUARTER NET LOSS 38.5 MILLION RUPEES VERSUS PROFIT 5
MILLION RUPEES YEAR AGO
* SEPT QUARTER REVENUE FROM OPERATIONS 289.1 MILLION RUPEES
VERSUS
401 MILLION RUPEES YEAR AGO
Source text: http://bit.ly/2AOkVOo
Further company coverage: JGSN.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Jagsonpal Pharmaceuticals
See all newsIndia's Jagsonpal Pharma jumps on purchase of wellness portfolio of Group Pharma
Brief: Jagsonpal Pharmaceuticals To Buy Wellness Portfolio Of Group Pharmaceuticals
Brief: Jagsonpal Pharmaceuticals Passes Buy-Back Resolution
Brief: Jagsonpal Pharmaceuticals Gets Order For Tax Demand Of 48.2 Million Rupees
India's Jagsonpal Pharmaceuticals jumps after plan to buyback shares